These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 10950366

  • 1. Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas.
    Swinnen LJ.
    Semin Oncol; 2000 Aug; 27(4):402-8. PubMed ID: 10950366
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
    Swinnen LJ.
    J Natl Cancer Inst Monogr; 2001 Aug; (28):38-43. PubMed ID: 11158205
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)--late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBV.
    Ibrahim HA, Menasce LP, Pomplun S, Burke M, Bower M, Naresh KN.
    Eur J Haematol; 2010 Sep; 85(3):227-30. PubMed ID: 20408873
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 5. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM.
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 7. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 8. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 10; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May 10; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 10; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 11. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug 10; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR, Nalesnik MA, Swerdlow SH.
    Am J Surg Pathol; 2006 Dec 10; 30(12):1604-12. PubMed ID: 17122518
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant lymphoproliferative disorder: a review.
    Loren AW, Porter DL, Stadtmauer EA, Tsai DE.
    Bone Marrow Transplant; 2003 Feb 10; 31(3):145-55. PubMed ID: 12621474
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.
    Markasz L, Stuber G, Flaberg E, Jernberg AG, Eksborg S, Olah E, Skribek H, Szekely L.
    BMC Cancer; 2006 Nov 13; 6():265. PubMed ID: 17101045
    [Abstract] [Full Text] [Related]

  • 15. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF.
    Hum Pathol; 2001 Sep 13; 32(9):963-9. PubMed ID: 11567226
    [Abstract] [Full Text] [Related]

  • 16. Treatment for Epstein-Barr virus-associated PTLD.
    Gross TG.
    Herpes; 2009 Jan 13; 15(3):64-7. PubMed ID: 19306606
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 13; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 18. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 19. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 27; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 20. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 27; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.